MedPath

A prospective study in adult patients with pituitary adenoma treated with radiotherapy excluding the hippocampal

Phase 3
Conditions
Health Condition 1: G938- Other specified disorders of brainHealth Condition 2: null- Patients above 18 years of age diagnosed with pituitary adenomas.
Registration Number
CTRI/2018/11/016345
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients must provide study-specific informed consent prior to study enrolment

2.Indication for adjuvant /radical radiotherapy

3.Patients who are treated in TMH Mumbai / ACTREC Navi Mumbai

4.Age > 18years

5.Patients consenting for the study

6.Karnofsky Performance Score of > 70

Exclusion Criteria

1. Prior history of irradiation to head & neck region

2. Contraindication to MR imaging such as implanted metal devices, severe claustrophobia etc

3. Acute medical illness requiring intensive medical care.

4. Any evidence of chronic / severe or uncontrolled medical illnesses

5. Patients with known major psychiatric illness, on antipsychotic medications and/or on electroconvulsive therapy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To evaluate feasibility of hippocampal sparing Intensity Modulated Radiotherapy for preserving neurocognitive functions in adults with pituitary adenomas. <br/ ><br>2) To evaluate radiotherapy dose constraints for hippocampus & its correlation with neurocognitive functions. <br/ ><br>Timepoint: After the completion of the study
Secondary Outcome Measures
NameTimeMethod
1) To evaluate changes in hippocampal perfusion using 99mECD SPECT after hippocampal sparing intensity modulated radiotherapy & its correlation with neurocognitive functions. <br/ ><br>2) To evaluate for any association between quality of life and doses received by different CNS structures Hippocampus, Hypothalamus, Cochlea, Optic nerve and optic chiasm. <br/ ><br>Timepoint: After the completion of the study
© Copyright 2025. All Rights Reserved by MedPath